1. Selection of suitable patients for second line therapy in rheumatoid arthritis;Pullar, T.; A, Capell H.;BrJ Rheumatol,1986
2. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14- year prospective evaluation of 1017 consecutive starts;Wolfe, F.; I, Hawley D.; A, Calney M.;Rheumatol,1990
3. The comparative efficacy and toxicity of second line drugs in rheumatoid arthritis;T, Felson D.; J, Anderson J.; F, Meenan R.;Arthritis Rheum,1990
4. Levamisole-a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis;A, Capell H.; A, Hunter J.; N, Rennie J.A.; M, Murdoch R.;Rheumatol,1981
5. Goldberg A A, Godfrey K E. Fenclofenac.Clin Rheum Dis 1980; 6.